Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.

van Bömmel F, Trojan J, Deterding K, Wedemeyer H, Wasmuth HE, Hüppe D, Möller B, Bock FJ, Feucht HH, Berg T.

Antivir Ther. 2012;17(6):1049-58. doi: 10.3851/IMP2307. Epub 2012 Aug 14.

PMID:
22892524
2.

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2010 Jan;51(1):73-80. doi: 10.1002/hep.23246.

PMID:
19998272
3.

[Laryngeal squamous cell carcinoma in a 12-year-old boy].

Muenscher A, Feucht HH, Kutta H, Tesche S, Wenzel S.

HNO. 2009 Jun;57(6):617-20. doi: 10.1007/s00106-008-1817-8. German.

PMID:
19455289
4.

Integration of human papilloma virus type 26 in laryngeal cancer of a child.

Muenscher A, Feucht HH, Kutta H, Tesche S, Wenzel S.

Auris Nasus Larynx. 2009 Apr;36(2):232-4. doi: 10.1016/j.anl.2008.05.011. Epub 2008 Jul 14.

PMID:
18621496
5.

Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

Steininger C, Graninger W, Zoufaly A, Zöllner B, Feucht HH, Kundi M, Stahmer I, Stellbrink HJ, van Lunzen J.

Eur J Med Res. 2008 Jun 24;13(6):304-8.

PMID:
18558558
6.

Biotypes of group A streptococci from patients with pharyngitis and soft tissue infections.

Opavski N, Mijac V, Cirković I, Feucht HH, Ranin L.

Clin Microbiol Infect. 2007 Mar;13(3):320-2.

7.

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2006 Aug;44(2):318-25.

PMID:
16871563
8.

Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier.

Zöllner B, Feucht HH, Sterneck M, Schäfer H, Rogiers X, Fischer L.

Liver Transpl. 2006 Aug;12(8):1283-9.

9.

Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.

Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH.

Intervirology. 2005;48(4):213-5.

PMID:
15920344
10.
11.

Fatal influenza A infection with Staphylococcus aureus superinfection in a 49-year-old woman presenting as sudden death.

Tsokos M, Zöllner B, Feucht HH.

Int J Legal Med. 2005 Jan;119(1):40-3. Epub 2004 Aug 19.

PMID:
15322829
12.

Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process.

Schroter M, Zollner B, Laufs R, Feucht HH.

J Infect Dis. 2004 Sep 15;190(6):1199-200; author reply 1200-1. No abstract available.

PMID:
15319872
13.

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

Hepatology. 2004 Jan;39(1):42-50.

PMID:
14752821
14.

Multiple infections with different HCV genotypes: prevalence and clinical impact.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

J Clin Virol. 2003 Jul;27(2):200-4.

PMID:
12829042
15.

A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Feucht HH.

J Clin Virol. 2003 May;27(1):69-73.

PMID:
12727531
16.
17.

[Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].

Laufs R, Polywka S, Feucht HH, Schröter M, Zöllner B, Oehler G.

Anaesthesist. 2002 Nov;51(11):884-9. Review. German.

PMID:
12434261
18.

Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Sterneck M, Fischer L, Feucht HH.

J Viral Hepat. 2002 Nov;9(6):455-9.

PMID:
12431209
19.

SENV-H viremia and liver transplantation: significant increase of the prevalence.

Schröter M, Laufs R, Sterneck M, Fischer L, Knödler B, Schäfer P, Zöllenr B, Feucht HH.

Blood. 2002 Aug 15;100(4):1518-9. No abstract available.

20.

Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Schröter M, Zöllner B, Schäfer P, Landt O, Lass U, Laufs R, Feucht HH.

J Clin Microbiol. 2002 Jun;40(6):2046-50.

21.

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH.

J Clin Microbiol. 2002 May;40(5):1866-8.

22.

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH.

Clin Infect Dis. 2002 May 1;34(9):1273-7. Epub 2002 Apr 2.

PMID:
11941556
23.

Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy.

Zöllner B, Schäfer P, Feucht HH, Schröter M, Petersen J, Laufs R.

J Med Virol. 2001 Dec;65(4):659-63.

PMID:
11745928
24.

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.

Albrecht D, Zöllner B, Feucht HH, Lorenzen T, Laufs R, Stoehr A, Plettenberg A.

J Clin Virol. 2002 Feb;24(1-2):93-8.

PMID:
11744433
25.

Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Virol. 2001 Dec;23(1-2):57-63.

PMID:
11595584
26.

Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.

Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.

J Med Virol. 2001 Jul;64(3):320-4.

PMID:
11424121
27.

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.

Zöllner B, Feucht HH, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R.

AIDS. 2001 May 4;15(7):935-6. No abstract available.

PMID:
11399967
28.

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH.

Lancet. 2001 Mar 24;357(9260):934-5.

PMID:
11289355
29.

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

J Clin Microbiol. 2001 Apr;39(4):1665-8.

30.
31.

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.

Zöllner B, Feucht HH, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2001 Apr;21(1):37-45.

PMID:
11255096
32.

Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

Nephron. 2001 Feb;87(2):139-42.

PMID:
11244308
33.

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2001 Feb;39(2):765-8.

34.

Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university pediatric hospital.

Elsner HA, Sobottka I, Feucht HH, Harps E, Haun C, Mack D, Ganschow R, Laufs R, Kaulfers PM.

Int J Hyg Environ Health. 2000 Oct;203(2):147-52.

PMID:
11109567
35.

Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation.

Mack D, Rohde H, Dobinsky S, Riedewald J, Nedelmann M, Knobloch JK, Elsner HA, Feucht HH.

Infect Immun. 2000 Jul;68(7):3799-807.

36.

Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment.

Eggers C, Stuerenburg HJ, Schafft T, Zöllner B, Feucht HH, Stellbrink HJ, van Lunzen J.

Ann Neurol. 2000 Jun;47(6):816-9.

PMID:
10852550
37.

In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R, Mack D.

Chemotherapy. 2000 Mar-Apr;46(2):104-10.

PMID:
10671760
38.

Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Schröter M, Polywka S, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2000 Feb;38(2):745-7.

39.

Low risk of vertical transmission of hepatitis C virus by breast milk.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

Clin Infect Dis. 1999 Nov;29(5):1327-9.

PMID:
10524987
40.

Drug-resistant genotyping in HIV-1 therapy.

Zöllner B, Feucht HH, Weitner L, Adam A, Laufs R.

Lancet. 1999 Sep 25;354(9184):1120-1. No abstract available.

PMID:
10509522
41.

High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up.

Feucht HH, Zöllner B, Schröter M, Polywka S, Buggisch P, Nolte H, Laufs R.

J Clin Virol. 1999 Jun;13(1-2):43-51.

PMID:
10405891
42.

Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Laufs R.

J Clin Microbiol. 1999 Aug;37(8):2576-80.

43.

Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Feucht HH, Schröter M, Zöllner B, Polywka S, Laufs R.

J Clin Microbiol. 1999 May;37(5):1294-7.

44.

Hepatitis G virus infection in liver transplant recipients.

Fischer L, Sterneck M, Feucht HH, Schuhmacher C, Malagó M, Rogiers X, Laufs R, Broelsch CE.

Transplant Proc. 1999 Feb-Mar;31(1-2):496-9. No abstract available.

PMID:
10083208
45.

Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha.

Fischer L, Sterneck M, Valentin-Gamazo C, Feucht HH, Malagó M, Broelsch CE.

Transplant Proc. 1999 Feb-Mar;31(1-2):494-5. No abstract available.

PMID:
10083207
46.
47.

TT virus viremia and liver transplantation: no significant increase of the prevalence.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Laufs R, Knödler B.

Blood. 1998 Dec 15;92(12):4877-8. No abstract available.

48.

Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination.

Mack D, Riedewald J, Rohde H, Magnus T, Feucht HH, Elsner HA, Laufs R, Rupp ME.

Infect Immun. 1999 Feb;67(2):1004-8.

49.

Definition of false-positive reactions in screening for hepatitis C virus antibodies.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Polywka S, Laufs R.

J Clin Microbiol. 1999 Jan;37(1):233-4.

50.

Transient dissociation between infectious HIV-1 titer and viral RNA during the early phase of AZT treatment.

Zöllner B, Stellbrink HJ, Feucht HH, Schröter M, Baumgartner EM, Laufs R.

Microbiol Immunol. 1998;42(6):471-3.

Supplemental Content

Loading ...
Support Center